Functional cholinergic damage develops with amyloid accumulation in young adult APPswe/PS1dE9 transgenic mice

Abstract We investigated the functional characteristics of pre- and postsynaptic cholinergic transmission in APPswe/PS1dE9 double transgenic mice at a young age (7-10 weeks) before the onset of amyloid plaque formation and at adult age (5-6 months) at its onset. We compared brain slices from cerebra...

Full description

Saved in:
Bibliographic Details
Published inNeurobiology of disease Vol. 38; no. 1; pp. 27 - 35
Main Authors Machová, Eva, Rudajev, Vladimír, Smyčková, Helena, Koivisto, Henna, Tanila, Heikki, Doležal, Vladimír
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.04.2010
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract We investigated the functional characteristics of pre- and postsynaptic cholinergic transmission in APPswe/PS1dE9 double transgenic mice at a young age (7-10 weeks) before the onset of amyloid plaque formation and at adult age (5-6 months) at its onset. We compared brain slices from cerebral cortex and hippocampus with amyloid deposits to slices from striatum with no amyloid plaques by 6 months of age. In young transgenic mice we found no impairments of preformed and newly synthesized [3 H]-ACh release, indicating intact releasing machinery and release turnover, respectively. Adult transgenic mice displayed a significant increase in preformed [3 H]-ACh release in cortex but a decrease in hippocampus and striatum. The extent of presynaptic muscarinic autoregulation was unchanged. Evoked release of newly synthesized [3 H]-ACh was significantly reduced in the cortex and hippocampus but unchanged in the striatum. Carbachol-induced G-protein activation in cortical membranes displayed decreased potency but normal efficacy in adult animals and no changes in young animals. These results indicate that functional pre- and postsynaptic cholinergic deficits are not present in APPswe/PS1dE9 transgenic mice before 10 weeks of age, but develop along with β-amyloid accumulation in the brain.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0969-9961
1095-953X
DOI:10.1016/j.nbd.2009.12.023